Skip to main content

AHG · Akso Health Group

Track AHG — free
$0.84 +0.11 (+14.93%) At close · Sep 11
Market Cap
$718.95M
Shares
856.70M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.84 Open$0.75 Day$0.74–0.84 52W close$0.73–2.50 Avg vol 30d19K Short int20K · 0.0% float · 1.0d Short vol43% DataAug 2020–Sep 2026

Raw chart and full-history price indicators begin at the captured split on Aug 24, 2020; bars on opposite sides are not compared.

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
Trailing 12 months
Net income (TTM)
Trailing 12 months
Revenue growth YoY
Year over year
Operating margin
Trailing 12 months
P / E (TTM)
Trailing earnings
FCF yield
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
Year over year · more shares
Price change (1Y)
-54.1%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −47%
below
Price vs 50-day avg −34%
below
RSI (14) 37
neutral
MACD trend Positive
52-week position 6%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −35%
trailing
6-month return −65%
trailing
YTD return −49%
this year
Relative strength −83%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+83% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of float · ▲ +3.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
11 holders — near 3-yr high, broad support
Squeeze score 21
low risk · 0–100
Fundamentals
Weak
Revenue growth −6%
Y/Y
Gross margin -0%
expanding
EPS growth −94%
Y/Y
Free cash flow $-12.8M
Buyback $25.0M
authorized
Quant / Vol
risk profile
Very High
Volatility 90%
annualized · 1-yr
Max drawdown −71%
past year
ATR 13.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−47% Bearish
Price vs 50-day avg
−34% Bearish
RSI (14)
37 Neutral
MACD trend
Positive Bullish
52-week position
6% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+83% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of float · ▲ +3.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
11 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1 Now $1 · 6% Range high $3
vs 200-day avg -47% vs 50-day avg -34%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Distribution — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AHG
Akso Health Group
this stock
$718.95M -48.8% -6.4% 0.0%
MCK
Mckesson Corp
$102.78B +7.5% +3.1% 23.7 2.4%
COR
Cencora, Inc.
$61.36B -4.8% +9.3% 23.9 2.4%
CAH
Cardinal Health Inc
$54.56B +14.1% +14.2% 2.9%
HSIC
Henry Schein Inc
$9.85B +16.9% +5.9% 25.8 7.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
11
% held
0.0%
Net QoQ
+54.7K sh
Top holder
RENAISSANCE TECHNOLOGIES…
Held Float
View
Held by Funds
Fund positions
2
View
Short & Settlement
Short Interest Rising
Shares short
19.6K
Days to cover
1.0d
Change
+641 sh
View
Short Volume
Short vol %
43%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
395
Value
$569
As of
Aug 3, 2026
View
Off-Exchange
Off-exchange %
56.4%
Week of
Aug 3, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$13.8M
Net income (FY)
$-18.7M
EPS diluted
$0.01
View
Buybacks
Authorized
$25.0M
View
Filings
SEC Filings
Latest
20-F
Filed
Jul 23, 2026
This year
4
View

Performance

Raw-price comparisons begin at the captured split on Aug 24, 2020; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
AHG -4.0% -35.5% -65.3% -6.8% -48.8%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -2.8% -33.7% -83.2% -6.4% -60.9%

Capital returns

Buyback program · as of Dec 10, 2018
Authorized
$25.00M
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1702318 CUSIP 98422P108 13F (30d) 2 filings 2 filers Visit website